Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grundy, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grundy, D
Topic Collections
Right arrowRelevant Article
Gut 2004;53:ii5
© 2004 by BMJ Publishing Group Ltd & British Society of Gastroenterology


PAPER

What activates visceral afferents?

D Grundy

Correspondence to:
Correspondence to:
D Grundy
Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield S10 2TN, UK; d.grundy{at}sheffield.ac.uk

Vagal and spinal afferents represent the information superhighways that convey sensory information from the gut to the central nervous system. These afferents are sensitive to both mechanical and chemical stimuli. Vagal afferents terminate in the muscle layers and in the mucosa. Muscle afferents are activated at physiological levels of distension and during peristalsis. In contrast, spinal afferents encode supraphysiological levels of intestinal pressure. Vagal and spinal afferents also express a wide range of membrane receptors to a variety of chemical mediators generated from both within and outside the gut wall. Some of these receptors are part of a modality specific transduction pathway involved in sensory signalling from the gut lumen to vagal afferent endings in the mucosa. Others, which are activated by substances derived from multiple cellular sources during ischaemia, injury, or inflammation act in a synergistic way to cause acute or chronic sensitisation of the afferent nerves to mechanical and chemical stimuli. Understanding the mechanisms that underlie hypersensitivity may have implications for the pharmaceutical approach to the treatment of functional bowel disorders like irritable bowel syndrome.


Keywords: afferents; central nervous system; nociceptors; transduction; visceral sensation; mechanosensitivity

Abbreviations: GI, gastrointestinal; CNS, central nervous system; IMAs, intramuscular arrays; IGLEs, intraganglionic laminar endings; EC, enterochromaffin; 5-HT, 5-hydroxytryptamine; CCK, cholecystokinin; PLC, phospholipase C; PGs, prostaglandins; ATP, adenosine triphosphate; NSCCs, non-selective cation channels; cAMP, cyclic adenosine 3', 5'-monophosphate; PLA2, phospholipase A2; AC, adenylate cyclase; PARs, protease activated receptors; COX-1, COX-2, cyclooxygenase-1 and 2; AA, arachidonic acid; DAG, diacylglycerol; IP3, inositol 1,4,5-trisphosphate


Relevant Article

Summary
M Costa, H Glise, and H Graffner
Gut 2004 53: ii22-ii25. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
GutHome page
M Costa, H Glise, and H Graffner
Summary
Gut, March 1, 2004; 53(90002): ii22 - 25.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Society of Gastroenterology